Evolving Treatment Options for the Treatment of HCC with Immunotherapy and LDT
This activity addresses ongoing research on emerging immunotherapy agents and clinical trial data on the use of these agents in combination, succession, and sequentially with interventional liver directed therapy (LDT).
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.